$14.05 -0.73 (-4.94%)
2/10/2012 4:00 PM

Dendreon Corp (NASDAQ:DNDN)

CAPS Rating: 2 out of 5

A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer.

Featured Broker Partners


Advertisement